NXGL logo

NEXGEL, Inc. Stock Price

NasdaqCM:NXGL Community·US$12.8m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

NXGL Share Price Performance

US$1.61
-2.22 (-57.95%)
US$6.00
Fair Value
US$1.61
-2.22 (-57.95%)
73.2% undervalued intrinsic discount
US$6.00
Fair Value
Price US$1.61
AnalystConsensusTarget US$6.00

NXGL Community Narratives

AnalystConsensusTarget·
Fair Value US$6 73.2% undervalued intrinsic discount

Hydrogel Adoption And Gentle Skincare Demand Will Drive Strong Long Term Upside

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$6
73.2% undervalued intrinsic discount
Revenue
37.63% p.a.
Profit Margin
0.12%
Future PE
20.07x
Price in 2028
US$0.08

Trending Discussion

Updated Narratives

NXGL logo

Hydrogel Adoption And Gentle Skincare Demand Will Drive Strong Long Term Upside

Fair Value: US$6 73.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with adequate balance sheet.

3 Risks
2 Rewards

NEXGEL, Inc. Key Details

US$11.7m

Revenue

US$6.9m

Cost of Revenue

US$4.8m

Gross Profit

US$7.6m

Other Expenses

-US$2.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.35
40.84%
-24.69%
11.0%
View Full Analysis

About NXGL

Founded
2009
Employees
19
CEO
Adam Levy
WebsiteView website
nexgel.com

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Recent NXGL News & Updates

Revenues Working Against NEXGEL, Inc.'s (NASDAQ:NXGL) Share Price Following 31% Dive

Nov 26
Revenues Working Against NEXGEL, Inc.'s (NASDAQ:NXGL) Share Price Following 31% Dive

Recent updates

No updates